SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-045841
Filing Date
2023-12-22
Accepted
2023-12-22 11:39:50
Documents
1
Period of Report
2023-12-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7314
  Complete submission text file 0001493152-23-045841.txt   9031
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Reporting) CIK: 0001689739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 231508167